QQ客服 官方微博 反馈留言

	Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: Results from a randomized controlled trial
	Zhu, Feng-cai; Chen, Wen; Hu, Yue-Mei; Hong, Ying; Li, Juan; Zhang, Xun; Zhang, Yi-Ju; Pan, Qin-Jing; Zhao, Fang-Hui; Yu, Jia-Xi
	2014
卷号	135期号:11页码:2612-2622
关键词	human papillomavirus vaccine China efficacy safety immunogenicity
ISSN号	0020-7136
DOI	10.1002/ijc.28897
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6685443
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhu, Feng-cai,Chen, Wen,Hu, Yue-Mei,et al. Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: Results from a randomized controlled trial[J],2014,135(11):2612-2622.
APA	Zhu, Feng-cai.,Chen, Wen.,Hu, Yue-Mei.,Hong, Ying.,Li, Juan.,...&Descamps, Dominique.(2014).Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: Results from a randomized controlled trial.,135(11),2612-2622.
MLA	Zhu, Feng-cai,et al."Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: Results from a randomized controlled trial".135.11(2014):2612-2622.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。